Objective: Na18F bone positron emission tomography (bone PET) is a new imaging modality which is useful for the evaluation of bone diseases. Here, we compared the diagnostic accuracies between bone PET and bone scan for the detection of bone metastasis (BM). Materials and Methods: Sixteen cancer patients (M:F = 10:6, mean age = 60 ± 12 years) who underwent both bone PET and bone scan were analyzed. Bone PET was conducted 30 minutes after the injection of 370 MBq Na18F, and a bone scan was performed 3 hours after the injection of 1295 MBq 99mTc-hydroxymethylene diphosphonate. Results: In the patient-based analysis (8 patients with BM and 8 without BM), the sensitivities of bone PET (100 % = 8/8) and bone scan (87.5 % = 7/8) were not signif...
It is unknown whether assessment of potential bone lesions in metastatic breast cancer (MBC) by F-18...
Objectives: We aimed to compare the role of 18F-fluoride PET/CT, FDG PET/CT and 99mTc-MDP bone scans...
Background Similar to the situation in other tumour types, it is currently unclear whether fluorodeo...
Introduction: The 18F-NaF positron emission tomography/computed tomography is being considered as an...
Objective: the aim of this study was to compare bone scintigraphy (BS) and positron emission tomogra...
Purpose: Conventional technetium-99m methylene diphosphate whole body bone scan (bone scan) has a hi...
Purpose: Due to the fact that fluorine-18-fluorodeoxyglucose positron emission tomography/computed t...
Despite advances in morphological imaging, some patients with non-small cell lung cancer (NSCLC) are...
Purpose: To assess the role of 18F-NaF PET/CT in the detection of metastatic bone disease compared t...
PURPOSE: The aim of this study was to compare the accuracy of fluorodeoxyglucose-positron emission t...
Purpose: Due to the fact that fiuorine-18-fiuorodeoxyglucose positron emission tomography/computed t...
PURPOSE: The aim of this study was to compare detection, lesion conspicuity and reader confidence of...
Purpose: Bone metastasis in breast cancer patients are usually assessed by conventional Tc-99m methy...
Aim: To investigate the role of 18F–NaF PET/CT and compare it with 99m Tc-MDP whole body bone scinti...
BACKGROUND: The roles of positron emission tomography and bone scanning in identifying bone metastas...
It is unknown whether assessment of potential bone lesions in metastatic breast cancer (MBC) by F-18...
Objectives: We aimed to compare the role of 18F-fluoride PET/CT, FDG PET/CT and 99mTc-MDP bone scans...
Background Similar to the situation in other tumour types, it is currently unclear whether fluorodeo...
Introduction: The 18F-NaF positron emission tomography/computed tomography is being considered as an...
Objective: the aim of this study was to compare bone scintigraphy (BS) and positron emission tomogra...
Purpose: Conventional technetium-99m methylene diphosphate whole body bone scan (bone scan) has a hi...
Purpose: Due to the fact that fluorine-18-fluorodeoxyglucose positron emission tomography/computed t...
Despite advances in morphological imaging, some patients with non-small cell lung cancer (NSCLC) are...
Purpose: To assess the role of 18F-NaF PET/CT in the detection of metastatic bone disease compared t...
PURPOSE: The aim of this study was to compare the accuracy of fluorodeoxyglucose-positron emission t...
Purpose: Due to the fact that fiuorine-18-fiuorodeoxyglucose positron emission tomography/computed t...
PURPOSE: The aim of this study was to compare detection, lesion conspicuity and reader confidence of...
Purpose: Bone metastasis in breast cancer patients are usually assessed by conventional Tc-99m methy...
Aim: To investigate the role of 18F–NaF PET/CT and compare it with 99m Tc-MDP whole body bone scinti...
BACKGROUND: The roles of positron emission tomography and bone scanning in identifying bone metastas...
It is unknown whether assessment of potential bone lesions in metastatic breast cancer (MBC) by F-18...
Objectives: We aimed to compare the role of 18F-fluoride PET/CT, FDG PET/CT and 99mTc-MDP bone scans...
Background Similar to the situation in other tumour types, it is currently unclear whether fluorodeo...